World of DTC Marketing

JUNE 2, 2021

SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. Here are some basics: 1ne: Physicians receive a lot of emails and don’t have time to read every one. 100 percent of U.S.

Physicians 180

Physicians Doctors Marketing Sales 180

World of DTC Marketing

SEPTEMBER 22, 2021

The onset of wrong, inaccurate, or confusing medical information forces people to go online or talk to their doctor about treatment options. Visting my doctor for my annual physical, I noticed huge LCD screens in each exam room with rotating ads for everything from prescription drugs to vitamins. Second, do people trust the FDA?

Doctors 43

Doctors Media Marketing Prescription 43

World of DTC Marketing

MARCH 11, 2022

Trust, for example, in physicians is still relatively high. Most patients completely trusted their physicians “to put their needs above all other considerations” (69%). But do doctors trust the system? Physician trust in the U.S. Physician trust in the U.S.

Physicians 212

Physicians Healthcare Healthcare Pharma 212

World of DTC Marketing

DECEMBER 23, 2020

How do physicians feel about patients asking for a new drug via a telehealth visit, and can the prescriber evaluate whether a patient is a good candidate or a new drug? The old belief is that patients who are interested in new treatments ask their doctor about them. Is TV the best channel? Today it’s a multichannel approach.

Prescription 249

Prescription Doctors Side effects Marketing 249

World of DTC Marketing

JANUARY 1, 2022

1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. Here are things I believe are more realistic. 3hree: Pharma will increase its spending in digital, but a lot of the money will be wasted.

Healthcare 244

Healthcare Healthcare Side effects Prescription 244

World of DTC Marketing

AUGUST 10, 2022

DTC pharma marketers must acknowledge that people’s days of seeing a TV ad and running to their doctor to ask for the product are all but gone. They’re using label and FDA-friendly language, which isn’t what patients want to hear. Use language that talks to patients as a physician would talk to them.

Marketing 252

Marketing Media Side effects Pharma 252

World of DTC Marketing

SEPTEMBER 24, 2021

Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place. Then, against the advisory panel’s advice, Aduhelm was approved, but insiders within the industry criticized both the FDA and Biogen weren’t sold on the drug or its price tag. Biogen is in trouble.

Insurance 222

Insurance Pharma Doctors Physicians 222

World of DTC Marketing

DECEMBER 22, 2020

But at the same time, 93% of doctors believe mHealth apps can improve patients’ health. Physicians are incorporating digital therapies into their patient encounters in increasing numbers. 56% of doctors have initiated the use of these tools and 26% of patients have asked about these tools.

Pharma 230

Pharma Doctors Patients Management 230

World of DTC Marketing

JULY 5, 2022

The FDA should require every pharma product website to devote part of its content to prevention and the importance of exercise. Why don’t doctors have the “the talk”? While the population is more worried about COVID, they are killing themselves by overeating processed food and not getting any exercise.

Insurance 200

Insurance Doctors Pharma Side effects 200

Pharmaceutical Technology

OCTOBER 1, 2022

The US Food and Drug Administration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS). The FDA approval is based on findings from the multicentre Phase II CENTAUR clinical trial that enrolled 137 ALS patients.

Food and Drug Administration 97

Food and Drug Administration FDA Prescription Medicine 97

pharmaphorum

SEPTEMBER 30, 2022

Patient organisations have been celebrating the FDA approval yesterday of Amylyx’ amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that arrived at different conclusions about the drug. The post Relief for Amylyx as FDA clears controversial ALS drug Relyvrio appeared first on.

FDA 98

FDA Doctors Patients Prescription 98

MedCepts

NOVEMBER 7, 2017

Doctors are natural skeptics. Remember, doctors were educated in scientific communities. Given the fact that numerous products sprout out year after year, it is the physician’s role to determine that these products are safe and effective for the patient. Dealing with doctors naturally follows a normal business relationship.

Physicians 52

Physicians Medical sales reps Doctors Medical sales 52

pharmaphorum

SEPTEMBER 1, 2022

Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. Our doctor consultations only cost $15, less than the average insurance copay. The platform.

Medical 98

Medical Prescription Doctors Physicians 98

Pharmaceutical Technology

AUGUST 12, 2022

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The FDA’s action plan. Thus, FDA funding could be what is needed on this front, says Cudkowicz.

FDA 98

FDA Food and Drug Administration Physicians Side effects 98

World of DTC Marketing

FEBRUARY 2, 2021

When I first read these statistics, I thought, “what a great opportunity,” but I wanted to check with some physician thought leaders. It is also important to ensure that the doctors oversee diagnosis. We see new medical data almost every day, some of which the FDA says is questionable. 2wo: Bad Data=Bad Suggestions?

Insurance 139

Insurance Doctors Healthcare Healthcare 139

PM360

OCTOBER 13, 2023

Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. doctors are calling two particular drugs “paradigm-shifting”—tirzepatide, sold as Mounjaro , and semaglutide, sold as the brands Ozempic , Wegovy , and Rybelsus.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

Evolve Your Success

NOVEMBER 1, 2022

In this first installment of this two-part series, Dr. Kupferman shares his take on the importance of medical sales reps to private practice physicians. Again, it’s revolutionizing the way medicine is practiced, and it’s a game-changer for private practice physicians and other physicians alike.

Medical 130

Medical Medical sales reps Doctors Medical sales 130

Evolve Your Success

OCTOBER 23, 2024

Discover how AI is enhancing physician capabilities by providing rapid feedback and enabling alternative diagnostic approaches, paving the way for a more proactive model of care. ” Justin is currently a doctoral candidate at Florida Tech, working on his dissertation at NYU Stern.

Medical 130

Medical Medical sales Healthcare Healthcare 130

PM360

NOVEMBER 21, 2022

Patient Pages: PatientPoint Reveals Patients Are Anxious About Talking with Doctors. A notable 69% of Americans worry that they won’t be able to understand the terminology their doctors use and the same number of patients wish they knew how to describe their symptoms better before talking to an HCP. following a COVID infection.

Healthcare 52

Healthcare Healthcare Physicians Doctors 52

PM360

NOVEMBER 29, 2022

1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. Orchestrated omnichannel engagement has grown into a buzz phrase for commercial teams ever since they started using digital communications channels to engage with doctors.

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

PM360

APRIL 7, 2023

Med Device Department: Medicare Sets Precedent for Virtual Reality Therapeutic Payments In November 2021, the FDA approved a virtual reality (VR) therapy that provides an immersive experience for relieving chronic lower back pain. Doctor Docs: HCPs Are Still Burnt Out But Remain Hopeful About Pricing Daniel S. One in three (33%) U.S.

Healthcare 52

Healthcare Healthcare Insurance Physicians 52

Pharma Marketing Network

MARCH 3, 2025

With physicians spending more time online and patients searching for medical information, pharma marketers must refine their digital strategies to create meaningful engagement. Imagine launching a campaign that reaches the right doctor at the right time or helps a patient understand treatment options without feeling overwhelmed.

Pharma 52

Pharma Patients Physicians Doctors 52

Pharma Marketing Network

MARCH 3, 2025

With physicians spending more time online and patients searching for medical information, pharma marketers must refine their digital strategies to create meaningful engagement. Imagine launching a campaign that reaches the right doctor at the right time or helps a patient understand treatment options without feeling overwhelmed.

Pharma 52

Pharma Patients Physicians Doctors 52

Legacy MEDSearch

JUNE 19, 2023

The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow® in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions. The US Food and Drug Administration has approved the use of iTFlow® in blood flow analysis.

FDA 52

FDA Food and Drug Administration Recruitment Physicians 52

PM360

AUGUST 9, 2022

2 and over a million actively licensed physicians 3 are available to prescribe them? Of the 50 new drugs approved by the FDA in 2021, a majority treated conditions affecting small patient populations. The 80/20 ratio varies by drug and the data sample of the top eight deciles ranges from 15-35% of prescribing doctors.

Prescription 52

Prescription Doctors Specialization Physicians 52

pharmaphorum

DECEMBER 22, 2022

Prediction 1: the FDA will become more directive and collaborative on guidelines for DCTs. The risk of not having these discussions is to conduct expensive trials only to discover too late that they were measuring the wrong endpoint, in the wrong way, or with a tool or technology the FDA does not accept.

FDA 97

FDA Patients Electronics Medical 97

Pharmaceutical Representative Training

DECEMBER 28, 2021

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.

Marketing 52

Marketing Food and Drug Administration Pharma Doctors 52

pharmaphorum

SEPTEMBER 12, 2022

Across LabCorp , we innovate through science and technology, with access to approximately 2,500 [doctors] and PhDs and over 700 patients. This reach allows us to support 82% of the novel drugs and therapeutic products approved by the US FDA, including 63% of those specific to oncology,” Reddy states. About the author.

Patients 105

Patients Medicine FDA Healthcare 105

PM360

DECEMBER 14, 2022

More than 83% of primary care physicians (PCPs) want their patients to talk about basic mental illness concerns so they can treat them themselves, but only one in four PCPs actually performed a depression screening, according to the latest GeneSight Mental Health Monitor , a nationwide survey from Myriad Genetics, Inc. FDA Update.

Healthcare 52

Healthcare Healthcare Doctors FDA 52

PM360

JUNE 24, 2024

DOCTOR DOCS HCPs Like Pharma Companies—Somewhat Pharma’s public perception has never been entirely favorable, but new data from CMI Media Group shows HCP perception of pharma companies is on the rise. CMI’s data reveals 61% of physicians from a range of specialities have a somewhat or very favorable view of pharmaceutical companies.

Media 59

Media FDA Physicians Pharma 59

MedReps

SEPTEMBER 19, 2022

Often we’re lucky if we even get to see our physicians, let alone overcome their objections regarding insurance coverage and competitive claims. Physician Access. Every year, another physician’s office or hospital system eliminates representative visits and lunches. Physician Apathy. Insurance Coverage.

Medical sales 66

Medical sales Medical sales reps Sales Medical 66

Celeritas

OCTOBER 12, 2022

Due to rigid FDA regulations, however, pharma financial resources are often depleted in generating drugs which fail to pass the approval process. In these circumstances, E-Detailers can be of great value because they can prompt the doctor to interact with both the MSL and the information.

Pharma 98

Pharma Marketing Sales Medical 98

pharmaphorum

AUGUST 11, 2022

Next, pharmacists review the participant’s genetic results – along with health data such as drug, lifestyle, and food interactions – to customize a “Medication Action Plan” that members’ physicians can access to determine which drugs should be prescribed to increase safety and efficacy.

Side effects 98

Side effects Medical Prescription Patients 98

PM360

JUNE 24, 2024

The financial consequences of delayed diagnosis range from paying for more frequent doctor visits and expensive medical equipment to requiring daily care and more—all of which could be avoided with earlier diagnosis. FDA Rare Diseases]([link] 2, 3. References: 1. EveryLife Foundation Delayed Diagnosis Study]([link] 4.

Patients 52

Patients Marketing Doctors Education 52

PM360

SEPTEMBER 7, 2023

Doctor Docs: HCPs on Social Media Platforms X vs. Threads Reaching HCPs where they prefer to consume content isn’t as simple with recent changes to the social media landscape. One doctor even said that Meta “bans” him anytime he says the word “cannabis.” The most shared links by HCPs were for Arexvy , Rinvoq , and Inpefa.

Healthcare 52

Healthcare Healthcare FDA Doctors 52

Pharmaceutical Technology

MARCH 24, 2023

Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year. In addition, two more Humira biosimilars are currently under FDA review and both are anticipated to launch in 2023.

Competition 59

Competition Marketing FDA Physicians 59

European Pharmaceutical Review

MARCH 4, 2024

Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5 The emergency use approval from the FDA of lipid nanoparticle- (LNP-) based mRNA vaccines during the COVID-19 pandemic attested the significance of LNPs.

Food and Drug Administration 98

Food and Drug Administration Transportation FDA Medical 98